Related references
Note: Only part of the references are listed.B-cell directed therapies in antiphospholipid antibody syndrome - New directions based on murine and human data
Saakshi Khattri et al.
AUTOIMMUNITY REVIEWS (2012)
Rituximab - Shadow, illusion or light?
Ronald F. van Vollenhoven
AUTOIMMUNITY REVIEWS (2012)
Management of refractory anti-phospholipid syndrome
Tina Scoble et al.
AUTOIMMUNITY REVIEWS (2011)
Management of refractory cases of catastrophic antiphospholipid syndrome
Gerard Espinosa et al.
AUTOIMMUNITY REVIEWS (2011)
Treatment-induced downregulation of antiphospholipid antibodies: effect of rituximab alone on clinical and laboratory features of antiphospholipid syndrome
S. Sciascia et al.
LUPUS (2011)
Non-criteria manifestations of antiphospholipid syndrome
D. Erkan et al.
LUPUS (2010)
Use of Rituximab in the Antiphospholipid Syndrome
Deepak Kumar et al.
Current Rheumatology Reports (2010)
Update of the guidelines for lupus anticoagulant detection
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Prevention of murine antiphospholipid syndrome by BAFF blockade
Philip Kahn et al.
ARTHRITIS AND RHEUMATISM (2008)
Mechanisms of killing by anti-CD20 monoclonal antibodies
Martin J. Glennie et al.
MOLECULAR IMMUNOLOGY (2007)
Limited effect of rituximab on thrombocytopaenia and anticardiolipin antibodies in a patient with primary antiphospholipid syndrome
P. R. J. Ames et al.
ANNALS OF HEMATOLOGY (2007)
Successful treatment of thrombocytopenia in primary antiphospholipid antibody syndrome with the anti-CD20 antibody rituximab-monitoring of antiphospholipid and anti-GP antibodies:: a case report
R Trappe et al.
ANNALS OF HEMATOLOGY (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura
P Brændstrup et al.
AMERICAN JOURNAL OF HEMATOLOGY (2005)
The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura
N Cooper et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
CTLA4Ig prevents initiation but not evolution of anti-phospholipid syndrome in NZW/BXSB mice
A Akkerman et al.
AUTOIMMUNITY (2004)
The antiphospholipid syndrome as a model for B cell-induced autoimmune diseases
P Youinou et al.
THROMBOSIS RESEARCH (2004)
Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus
E Kozora et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer
Y Shoenfeld et al.
LUPUS (2003)
Share Paper
